BMO Capital lowered the firm’s price target on Accenture (ACN) to $325 from $355 and keeps a Market Perform rating on the shares after its Q4 results and guidance. The company’s outlook was better than the firm’s expectations, its bookings were weak, albeit against a very difficult compare, the analyst tells investors in a research note. Accenture is also facing a 2-point revenue growth headwind in Q4 from the federal business due to both cancelations and slower new business trends, the firm added.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.